Eloine is a prescription-only combined oral contraceptive containing drospirenone 3mg and ethinylestradiol 0.02mg per active tablet, with 3, 6 and 12 month courses sold by Ways Pharmacy (UK) only after clinical approval.
Key facts
| Active ingredients | Drospirenone 3mg and ethinylestradiol 0.02mg |
|---|---|
| Format | Tablets in a 28-day cycle strip |
| Cycle | 24 active light pink tablets followed by 4 white inactive tablets |
| Pack options | 3-month (84), 6-month (168) or 12-month (336) courses |
| Licensed use | Oral contraception |
| Legal classification | POM — Prescription Only Medicine |
| Supply | Only after clinical consultation and approval |
Who it is for
- Women for whom a prescriber or pharmacist has confirmed that Eloine is a clinically appropriate combined oral contraceptive.
Not suitable for: Do not use without clinical approval. It is not suitable in pregnancy or breastfeeding, or with a history of blood clots, stroke, heart disease, migraine with aura, uncontrolled high blood pressure or severe liver disease.
How to use
- Complete the clinical consultation before supply.
- Read the Patient Information Leaflet (PIL) supplied with the medicine.
- Take one tablet daily at the same time each day, following the arrows on the strip.
- After the 24 active tablets, take the 4 white inactive tablets, then start a new strip without a break.
Frequently asked questions
What does Eloine contain?
Each active tablet contains drospirenone 3mg and ethinylestradiol 0.02mg.
How is the 28-day cycle arranged?
Each cycle has 24 active light pink tablets followed by 4 white inactive tablets, with no break between packs.
Which course lengths are available?
3-month (84 tablets), 6-month (168 tablets) and 12-month (336 tablets) courses, subject to clinical approval.
Is a consultation required?
Yes. Eloine is a prescription-only medicine and supply depends on clinical approval.
What if a tablet is missed?
Follow the missed-pill instructions in the PIL; additional contraception may be required after a late active tablet.
Safety and storage
- Use only for the person and course approved after consultation.
- Seek urgent medical help for possible blood-clot symptoms such as sudden chest pain, breathlessness or painful leg swelling.
- Store below 25°C in the original packaging and keep out of the sight and reach of children.
- Read the PIL. Report suspected side effects through the MHRA Yellow Card scheme.
This page provides factual information about a prescription-only medicine and is not an advertisement to the public. Supply requires clinical approval.
Reviews
There are no reviews yet.